Yasser Abuetabh
Edmonton, AB T6G2S2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone esters.
Journal: JCI insight
Published: November 10, 2025
Ketone therapy prevents semaglutide-induced loss of cardiac mass.
Journal: European journal of preventive cardiology
Published: August 04, 2025
Reply: The Impact of Semaglutide on Cardiac Mass and Function Requires Further Investigation.
Journal: JACC. Basic to translational science
Published: February 27, 2025
Semaglutide Reduces Cardiomyocyte Size and Cardiac Mass in Lean and Obese Mice.
Journal: JACC. Basic to translational science
Published: January 17, 2025
The SWIB/MDM2 motif of UBE4B activates the p53 pathway.
Journal: Molecular therapy. Nucleic acids
Published: September 14, 2022
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.
Journal: Experimental & molecular medicine
Published: June 05, 2022
Regulation of the tumor suppressor PTEN in triple-negative breast cancer.
Journal: Cancer letters
Published: September 20, 2021
p63, a key regulator of Ago2, links to the microRNA-144 cluster.
Journal: Cell death & disease
Published: September 09, 2021
Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
Journal: Nucleic acids research
Published: October 05, 2020
Cancer Stem Cells and their Management in Cancer Therapy.
Journal: Recent patents on anti-cancer drug discovery
Published: April 08, 2020
Last Updated: 09/26/2026